Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Pediatr Transplant. 2010 Jan 4;14(4):534–539. doi: 10.1111/j.1399-3046.2009.01268.x

Table 1.

Patient demographics by acute rejection (AR) group (Note: A0 episodes and ‘B’ grades are ignored)

No acute rejection One A1 One A2 Multiple A1 Multiple A2 Multiple AR of mixed types

N N N N N N

Median age at transplant (P25, P75) [yr] 108 10.3 (1.4, 15.1) 50 13.7 (7.4, 16.6) 44 12.0 (5.1, 15.4) 34 12.4 (7.6, 15.7) 73 14.2 (12.0, 16.1) 73 13.2 (10.2, 16.2)

Gender
Male 69 64% 21 42% 24 59% 20 59% 43 59% 49 66%
Female 39 36% 29 58% 20 41% 14 41% 30 41% 25 34%

Cystic fibrosis 38 35% 27 54% 21 48% 18 53% 50 69% 54 73%

Type of transplant
Single lung 1 1% 0 0% 0 0% 1 3% 3 4% 1 1%
Double lung 74 79% 37 74% 33 75% 28 82% 61 84% 62 84%
Heart/lung 25 23% 10 20% 7 16% 5 15% 3 4% 7 10%
Living donor 7 7% 3 6% 4 9% 0 0% 6 8% 4 5%

Induction therapy
No 60 59% 25 57% 23 58% 16 52% 42 61% 37 56%
Yes 41 41% 19 43% 17 42% 15 48% 27 39% 29 44%

Maintenance
Cyclosporine 77 71% 32 64% 32 73% 20 59% 63 86% 52 71%
Tacrolimus 31 29% 18 36% 12 27% 14 41% 10 14% 21 29%